Topic

Titan Pharmaceuticals

A collection of 2 issues

Titan Pharmaceuticals Reports $763K Q3 Net Loss

Titan Pharmaceuticals reveals a $763,000 net loss in Q3, translating to a 83 cents per share loss. Discover the impact on Titan's financial performance.

Titan Pharmaceuticals Reports $763,000 Q3 Loss

Titan Pharmaceuticals faces a $763,000 loss in Q3, impacting its financial outlook. Explore the Q3 results and future prospects in this financial report.